For instance, recent studies demonstrated that deletion of the m6A demethylase ALKBH5 sensitizes tumors to cancer immunotherapy by reducing the accumulation of MDSCs and Tregs within the microenvironment [78]. This evidence concerns the gene ALKBH5 and cancer.